iMedX - About the company
iMedX is an acquired company based in Atlanta (United States), founded in 2002 by Venkat Sharma. It operates as a RCM and clinical documentation solutions optimizing healthcare revenue and patient care. iMedX has raised $22.3M in funding from RFE Investment Partners. The company has 404 active competitors, including 37 funded and 48 that have exited. Its top competitors include companies like Infinx, Medusind and R1 RCM.
Company Details
RCM and clinical documentation solutions optimizing healthcare revenue and patient care. They streamline revenue cycle management and create insightful clinical documentation for physician groups and hospitals. Their solutions enable doctors to focus on patients. They offer medical coding and auditing services, ensuring accurate coding and compliance. They focus on core measures, tracking key performance indicators to improve healthcare quality. They provide clinical documentation services, converting medical dictations into clear patient records. They offer revenue cycle management solutions, improving financial processes and operational efficiency. They leverage technology and expertise to optimize operations and improve clinical outcomes. Their solutions simplify billing and insurance claims. They ensure clinical documentation is accurate and compliant. They provide data-driven insights into billing operations and clinical performance, enabling informed decisions and business growth. They offer AI medical coding, coding audits, and coding for hospitals and physician groups. They are a B2B company offering software and services.
- Website
- imedx.com
- Email ID
- *****@imedx.com
- Phone Number
- +1 **********
- Registered Address
- Atlanta, Georgia
Key Metrics
Founded Year
2002
Location
Atlanta, United States
Stage
Acquired
Total Funding
$22.3M in 5 rounds
Latest Funding Round
Investors
Ranked
12th among 404 active competitors
Employee Count
588 as on Jul 31, 2026
Exit Details
Acquired by Rapid Care (Jun 01, 2023)
Legal entities associated with iMedX
iMedX is associated with 3 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
IMEDX INC CIN: 32056972170 , United States, Active | - | - | - | |
IMEDX INFORMATION SERVICES PRIVATE LIMITED CIN: U72400TG2005PTC045430 , India, Active | Feb 22, 2005 | ₹10 - ₹50 Cr (As on Mar 31, 2023) | 126 (As on Mar 31, 2023) | |
IMEDX CIN: 205095500 , United States, Active | Dec 31, 1999 | - | 270 (As on Dec 31, 2019) | - |
iMedX's acquisition details
iMedX got acquired by Rapid Care on Jun 01, 2023.
Click here to take a look at iMedX's acquisition in detail
Sign up to download iMedX's company profile
iMedX's funding and investors
iMedX has raised a total funding of $22.3M over 5 rounds. Its first funding round was on Jul 14, 2009. Its latest funding round was a Series B round on Dec 24, 2013 for $*****. 2 investors participated in its latest round. iMedX has 3 institutional investors.
Here is the list of recent funding rounds of iMedX:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 24, 2013 | 1041419 | Series B | 9204111 | 2642524 | 7918102 | 5057991 |
Oct 05, 2011 | 8188046 | Series B | 2580218 | 3532460 | 5944796 | 1824191 |
Jan 12, 2011 | 1299882 | Series B | 5625145 | 9101903 | 9226752 | 8323419 |
View details of iMedX's funding rounds and investors
iMedX's founders and board of directors
Founder? Claim ProfileThe founders of iMedX is Venkat Sharma.
Here are the details of iMedX's key team members:
- Venkat Sharma: Founder of iMedX and founder of 2 other companies, CPA Innovations and Advantum Health. They are also an angel investor in 1 startup.Contact Info: 1 email address
View details of iMedX's Founder profiles and Board Members
iMedX's employee count trend
iMedX has 588 employees as of Jul 26. Here is iMedX's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
iMedX's Competitors and alternates
Top competitors of iMedX include Infinx, Medusind and R1 RCM. Here is the list of Top 10 competitors of iMedX, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Infinx 2010, Spring (United States), Series D | Provider of platform for revenue cycle management | $186M | 69/100 | |
2nd | Medusind 2002, Miami (United States), Acquired | Provider of medical and dental revenue cycle management service solutions | - | 68/100 | |
3rd | R1 RCM 2003, Chicago (United States), Acquired | Provider of AI-driven solutions for healthcare revenue cycle management and operations | - | 66/100 | |
4th | Commure 2016, Mountain View (United States), Series E | Provider of artificial intelligence software for healthcare revenue cycle management | $623M | 65/100 | |
5th | GeBBS 2005, East Haven (United States), Acquired | Provider of technology-enabled revenue cycle management and risk adjustment services for healthcare organizations | - | - | 65/100 |
6th | Xifin 1997, San Diego (United States), Acquired | Cloud-based billing & revenue cycle management solutions for diagnostic service providers | $6M | 64/100 | |
7th | Janus AI 2020, Chicago (United States), Series B | AI and SaaS-based revenue cycle management tool for healthcare providers | $64M | 62/100 | |
8th | Camber 2021, United States, Series B | Developer of revenue cycle management software for healthcare specialty providers | $50M | 60/100 | |
9th | ![]() Superdial 2021, San Francisco (United States), Series A | Provider of AI voice agents automating healthcare revenue cycle tasks | $20M | 60/100 | |
10th | Waystar 2000, Duluth (United States), Public | AI-powered healthcare revenue cycle management solutions for financial and operational success | - | 59/100 | |
12th | iMedX 2002, Atlanta (United States), Acquired | RCM and clinical documentation solutions optimizing healthcare revenue and patient care | $22.3M | 57/100 |
Looking for more details on iMedX's competitors? Click here to see the top ones
iMedX's Investments and acquisitions
iMedX has not made any investments yet. iMedX has made 6 acquisitions.Here is the list of latest three $acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Jul 08, 2019 | Acquisition | 2003 | Sugar Land (United States) | |
Jul 08, 2019 | Acquisition | 2004 | Warren (United States) | |
Jan 06, 2016 | Acquisition | 1999 | Melbourne (Australia) |
See all acquisitions by iMedX
Reports related to iMedX
Here is the latest report on iMedX's sector:
News related to iMedX
Media has covered iMedX for 1 event in last 1 year.
•
AI Healthcare firm Heidi Health raises $110m after NZ deploymentNZ Herald•Oct 06, 2025•Meta, Heidi, iMedX, Point72 and 5 others
•
Allison Davis joins Wiley as employee relations director, APACPeople Matters•May 06, 2022•Wiley Education Services, iMedX
•
iMedX, Inc. Launches Industry Leading Analytics and Business Intelligence with Acquisition of Prevalent, Inc. and Axcension, Inc.Business Today•Jul 08, 2019•iMedX, Prevalent, Axcension
•
iMedX Awarded Contract With Vizient To Provide Medical Transcription ServicesPR Newswire•Jun 06, 2017•iMedX, Vizient
•
Xconomy: iMedX Garners $4,034,263 New FinancingXconomy•Dec 26, 2013•iMedX, RFE Investment Partners, Ventureast
•
•
iMedX to Expand Healthcare Service Lines with Addition of HICMSPR Newswire•iMedX
Are you a Founder ?
FAQs about iMedX
Explore our recently published companies
- Persistent Petrochem - Mumbai based, 2022 founded, Unfunded company
- SoftTalk - Noida based, 2026 founded, Unfunded company
- Gravity Base - Dubai based, 2014 founded, Unfunded company
- Terablaz Media - Ahmedabad based, 2023 founded, Unfunded company
- Way2Max - Jaipur based, 2021 founded, Unfunded company
- IATrain - Picos based, 2024 founded, Unfunded company
